| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |